Related Experiment Video
Updated: Oct 15, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
[Effect of suprainhibitory (supra-MIC) concentration of clindamycin on endotoxin release from Bacteroides fragilis]
A Rokosz1, F Meisel-Mikołajczyk
1Zakład Mikrobiologii Lekarskiej AM w Warszawie.
Abstract:
The aim of this work was to determine the influence of clindamycin at concentration 100 x MIC on the growth of culture and the induction of endotoxin release from the cells of standard B. fragilis IPL E 323 strain. The antibiotic was added to 24-hour culture of the strain in BHI medium (time 0), its final concentration was 12.5 mg/l. The samples for further examinations were collected at time 0 and after 1, 2, 3 and 24 hours of continued incubation. At the same time the strain was cultured in a medium without the antibiotic. The optical density (OD 420 nm) of each sample was determined, they were centrifuged (2000 x g, 10 min), the supernatants were filtered (0.45 micron filters) and concentrated three times (5000 D ultrafilters). Two serological methods were applied to detect the presence of endotoxin in filtrates of culture medium: immunoelectroprecipitation (IEP) and immunoenzymatic assay (dot-ELISA) with rabbit anti-IPL E 323 immune serum. The results of experiments performed with filtrates of culture without the antibiotic indicate that standard B. fragilis IPL E 323 strain liberates endotoxin spontaneously to the culture medium. Single suprainhibitory dose of clindamycin at concentration 100 x MIC inhibits the growth of examined strain and does not cause augmented release of endotoxin from B. fragilis cells in vitro.
Insights
Clindamycin, at 100 times the minimum inhibitory concentration (MIC), inhibits *Bacteroides fragilis* growth. This high dose does not increase endotoxin release from the bacterial cells in vitro.
Area of Science:
- Microbiology
- Pharmacology
- Immunology
Background:
- *Bacteroides fragilis* is an opportunistic pathogen.
- Endotoxins are critical virulence factors in Gram-negative bacteria.
- Understanding antibiotic effects on endotoxin release is crucial for managing infections.
Purpose of the Study:
- To investigate the impact of a high clindamycin concentration (100 x MIC) on *B. fragilis* growth.
- To determine if this clindamycin dose induces augmented endotoxin release from *B. fragilis* cells.
Main Methods:
- *B. fragilis* IPL E 323 strain cultured in BHI medium with or without clindamycin (12.5 mg/l).
- Optical density measured to assess bacterial growth.
- Supernatants analyzed for endotoxin using immunoelectroprecipitation (IEP) and dot-ELISA.
Main Results:
- *B. fragilis* IPL E 323 spontaneously releases endotoxin into the culture medium.
- Clindamycin at 100 x MIC significantly inhibited bacterial growth.
- No augmented endotoxin release was observed from *B. fragilis* cells treated with high-dose clindamycin.
Conclusions:
- A suprainhibitory dose of clindamycin effectively inhibits *B. fragilis* growth in vitro.
- This specific high concentration of clindamycin does not lead to increased endotoxin release, suggesting a potentially favorable safety profile regarding endotoxemia during treatment.
More Related Videos
Related Concept Videos
Dysbiosis of the Gut Microbiota
Bacterial Toxins

